| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/03/2007 | WO2007049586A1 Therapeutic agent for ulcerative colitis and/or crohn's disease |
| 05/03/2007 | WO2007049582A1 Thiopeptide compound |
| 05/03/2007 | WO2007049575A1 Taxane compound with azetidine ring structure |
| 05/03/2007 | WO2007049553A1 Agent for treatment of circulatory failure |
| 05/03/2007 | WO2007049532A1 Aminodihydrothiazine derivative |
| 05/03/2007 | WO2007049304A2 Stable coated pharmaceutical formulation of olanzapine and process for preparing the same |
| 05/03/2007 | WO2007049303A2 An improved process for the preparation of highly pure fexofenadine |
| 05/03/2007 | WO2007049302A2 An improved process for the preparation of pure venlafaxine |
| 05/03/2007 | WO2007049293A1 An improved process for preparation of irbesartan |
| 05/03/2007 | WO2007049292A1 Pharmaceutical formulation of losartan |
| 05/03/2007 | WO2007049276A2 Compositions for- detecting of influenza viruses and kits and methods using same |
| 05/03/2007 | WO2007049265A2 Anti mineralocorticoid therapy of infection |
| 05/03/2007 | WO2007049262A1 Methods and compositions for the promotion of neuronal growth and the treatment of asociality and affective disorders |
| 05/03/2007 | WO2007049224A1 Novel hexahydro- or octahydro-cyclopenta[c]pyrrole derivatives |
| 05/03/2007 | WO2007049123A1 Histamine-3 receptor antagonists |
| 05/03/2007 | WO2007049121A1 Crystal form of sodium; (3r,5r)-7-[4-benzylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-imidazol-1-yl]-3,5-dihydroxy-heptanoate |
| 05/03/2007 | WO2007049119A1 A novel compound, useful for pancreatic lipase inhibition and the process for isolation thereof |
| 05/03/2007 | WO2007049089A1 Method of stimulating growth of functional blood vessels and/or regeneration of myocardium in damaged tissues |
| 05/03/2007 | WO2007049088A1 Method of stimulating growth of functional blood vessels and/or regeneration of myocardium in damaged tissues |
| 05/03/2007 | WO2007049085A1 Process for the preparation of sour cherry seed extract, use of the extract for the preparation of pharmaceutical compositions and pharmaceutical compositions containing said extract |
| 05/03/2007 | WO2007049050A2 Modulators of gpr40 for the treatment of diabetes |
| 05/03/2007 | WO2007049043A2 Tnf alpha ngf molecular switch for determining cell fate |
| 05/03/2007 | WO2007049041A1 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer |
| 05/03/2007 | WO2007048986A1 Novel method for preparing quaternary acid and ammonium salts |
| 05/03/2007 | WO2007048918A1 Novel esterified amino compounds having a hydrocarbon ring e with six camptothecin analogue ring members, preparation method thereof and pharmaceutical compositions containing same |
| 05/03/2007 | WO2007048917A1 Novel esterified amino compounds having a hydrocarbon ring e with seven camptothecin-derived ring members, preparation method thereof and pharmaceutical compositions containing same |
| 05/03/2007 | WO2007048870A1 Quetiapine hemifumarate purification by crystallization |
| 05/03/2007 | WO2007048848A2 V-atpase inhibitors for use in the treatment of septic shock |
| 05/03/2007 | WO2007048847A2 Indole and azaindole derivatives for the treatment of inflammatory and autoimmune diseases |
| 05/03/2007 | WO2007048846A1 Use of iron-chelating compounds, cyclic adenosine monophosphate-increasing compounds or combinations thereof for treating axonal lesions in the cns |
| 05/03/2007 | WO2007048843A2 Imidazo-pyridine containing beta agonists, method for producing them and their use as drugs |
| 05/03/2007 | WO2007048842A1 Benzimidazole derivatives for use as beta-3 receptor agonists |
| 05/03/2007 | WO2007048840A1 Novel beta-agonists, process for their preparation and their use as medicaments |
| 05/03/2007 | WO2007048820A2 Micronised azodicarbonamide, the preparation and use thereof |
| 05/03/2007 | WO2007048811A1 Pharmaceutical compositions comprising tricalcium phosphate and calcium carbonate |
| 05/03/2007 | WO2007048803A1 Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
| 05/03/2007 | WO2007048802A1 (hetero)aryl compounds with mch antagonistic activity and medicaments comprising these compounds |
| 05/03/2007 | WO2007048801A2 Sexual desire enhancing medicaments comprising benzimidazolone derivatives |
| 05/03/2007 | WO2007048788A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 05/03/2007 | WO2007048787A1 Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors |
| 05/03/2007 | WO2007048779A1 Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists |
| 05/03/2007 | WO2007048771A1 Arylurea derivatives as modulators of chemokine receptor activity |
| 05/03/2007 | WO2007048767A1 Squaric acid derivatives as inhibitors of histone deacetylase |
| 05/03/2007 | WO2007048643A1 Novel compound |
| 05/03/2007 | WO2007048595A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 05/03/2007 | WO2007048557A1 Protease inhibitors |
| 05/03/2007 | WO2007048523A1 Ophthalmic pharmaceutical compositions based on amino acids and sodium hyaluronate |
| 05/03/2007 | WO2007048522A1 Wound-healing pharmaceutical compositions in the form of a cream based on amino acids and sodium hyaluronate |
| 05/03/2007 | WO2007048510A1 Rxr agonists and antagonists, alone or in combination with ppar ligands, in the treatment of metabolic and cardiovascular diseases |
| 05/03/2007 | WO2007048471A1 Food composition |
| 05/03/2007 | WO2007048357A1 Interferon-alpha and c-phycocyanin for the treatment of autoimmune diseases, allergic diseases and cancer |
| 05/03/2007 | WO2007048353A1 Pharmaceutical composition and method for neoangiogenesis/revascularization useful in treating ischemic heart diseases |
| 05/03/2007 | WO2007048352A1 Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries |
| 05/03/2007 | WO2007048351A1 The oral agent for improving and protecting the function of joint comprising hyaluronic acid-phospholipid complexes |
| 05/03/2007 | WO2007048332A1 A pharmaceutical composition for treating gout and its preparation and use |
| 05/03/2007 | WO2007048311A1 Pharmaceutical composition having a ruthenium oxalato compound and method of using the same |
| 05/03/2007 | WO2007048233A1 Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist |
| 05/03/2007 | WO2007048225A1 A 4-oxo-1- (3-substituted phenyl) -1, 4-dihydro-1, 8-naphthyridine-3-carboxamide phosphodiesterase-4-inhibitor and a method of preparing same |
| 05/03/2007 | WO2007048224A1 Iap bir domain binding compounds |
| 05/03/2007 | WO2007048202A1 Methods and compositions for modulating wound repair |
| 05/03/2007 | WO2007048190A1 Macromolecular compounds having controlled stoichiometry |
| 05/03/2007 | WO2007035734A3 Cytotoxin compounds and methods of isolation |
| 05/03/2007 | WO2007032936A3 Azafused cyclin dependent kinase inhibitors |
| 05/03/2007 | WO2007031621A3 Metronidazole-based dermatological foam and emulsions for the production thereof |
| 05/03/2007 | WO2007031620A3 Metronidazole-based dermatological foam and emulsions for the production thereof |
| 05/03/2007 | WO2007030944A3 Methods of cardioprotection using dichloroacetate in combination with an inotrope |
| 05/03/2007 | WO2007030939A3 Methods of modulating neurotrophin-mediated activity |
| 05/03/2007 | WO2007030934A3 Methods of modulating neurotrophin-mediated activity |
| 05/03/2007 | WO2007030848A3 Non-fluorescent chlorophyll catabolites |
| 05/03/2007 | WO2007030697A3 Modulation of neurogenesis by hdac inhibition |
| 05/03/2007 | WO2007029251A3 Polyalkylene glycol derivatives of 4- (phenylamino)quinazolines useful as irreversible inhibitors of epidermal gr0wth fact0r receptor tyrosine kinase |
| 05/03/2007 | WO2007028821A3 Treatment of autoimmune diseases |
| 05/03/2007 | WO2007027855A3 Raf inhibitor compounds and methods of use thereof |
| 05/03/2007 | WO2007027734A3 Bicyclic and bridged nitrogen heterocycles |
| 05/03/2007 | WO2007027528A3 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-.receptor tyrosine kinases |
| 05/03/2007 | WO2007026219A3 Combinations of a 5-ht1b antagonist with a noradrenalin re-uptake inhibitor or a serotonin noradrenalin reutake inhibitor for treating cns conditions |
| 05/03/2007 | WO2007026041A3 Compuestos quinónicos antitumorales y sus derivados, procedimiento de obtención y sus aplicaciones |
| 05/03/2007 | WO2007025781A3 Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques |
| 05/03/2007 | WO2007025776A3 Cysteine protease inhibitors |
| 05/03/2007 | WO2007023342A3 Process of making geminal bisphosphonic acids and pharmaceutically acceptable salts and/or hydrates thereof |
| 05/03/2007 | WO2007023110A3 P38 map kinase inhibitors and methods for using the same |
| 05/03/2007 | WO2007023072A3 Use of ambroxol for the treatment of rhinovirus infections |
| 05/03/2007 | WO2007022947A3 5-ring heteroaromatic compounds and their use as binding partners for 5-ht5 receptors |
| 05/03/2007 | WO2007022535A3 Prodrugs of active agents |
| 05/03/2007 | WO2007022488A3 Crystalline rosuvastatin intermediate |
| 05/03/2007 | WO2007022269A3 Compounds and compositions as tpo mimetics |
| 05/03/2007 | WO2007021982A3 Modulators of cystic fibrosis transmembrane conductance regulator |
| 05/03/2007 | WO2007021858A3 Methods of making radiolabeled tracers and precursors thereof |
| 05/03/2007 | WO2007021711A3 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 05/03/2007 | WO2007020314A3 Formulation of natural triterpenes obtained from the genus olea in liposomes |
| 05/03/2007 | WO2007020313A3 Nutraceutical composition obtained from natural triterpenes |
| 05/03/2007 | WO2007019439A3 Block copolymer compositions and uses thereof |
| 05/03/2007 | WO2007019427A3 Methods and compositions for preserving the viability of photoreceptor cells |
| 05/03/2007 | WO2007018998A3 Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators |
| 05/03/2007 | WO2007016028A3 Synthesis and crystalline forms of npy5 antagonist |
| 05/03/2007 | WO2007013936A3 Method for treating nervous system disorders and conditions |
| 05/03/2007 | WO2007011626A3 Histone deacetylase inhibitors |
| 05/03/2007 | WO2007010337A8 Use of phosphodiesterase type 5 inhibitors for the prevention and treatment of diseases or health disorders and dispensing system for said inhibitors |
| 05/03/2007 | WO2007010013A3 Combination comprising a pyrimidylaminobenzamides and a flt-3 inhibitor for treating proliferative diseases |
| 05/03/2007 | WO2007009462A3 Treatment of migraine and headaches |